Investors

Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:

Stock Quote

Price

Change

High

View Details Stock Lookup

Date	Title and Summary
Toggle Summary 01 Apr '20	Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR) - Etrasimod CR profile designed to retain etrasimod's rapid onset of action while further improving its potentially best-in-class, non-titrated, low intrinsic first-dose heart rate effect - Positive topline data from Phase 1 study demonstrated significant reduction in heart rate effect, General
Toggle Summary 30 Mar '20	Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor SAN DIEGO , March 30, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that James C. Mullen has agreed to serve as an independent senior advisor to the Company. "We are honored to have Jim as an advisor to Arena. In a rapidly evolving industry, and especially in General

Date

Title and Summary

Apr '20

Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR)

- Etrasimod CR profile designed to retain etrasimod's rapid onset of action while further improving its potentially best-in-class, non-titrated, low intrinsic first-dose heart rate effect - Positive topline data from Phase 1 study demonstrated significant reduction in heart rate effect,

General

Mar '20

Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor

SAN DIEGO , March 30, 2020 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that James C. Mullen has agreed to serve as an independent senior advisor to the Company. "We are honored to have Jim as an advisor to Arena. In a rapidly evolving industry, and especially in

General